An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of Sildenafil Following Fasted Administration Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered With Or Without Water Relative To Viagra Oral Tablet With Water.

Trial Profile

An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of Sildenafil Following Fasted Administration Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered With Or Without Water Relative To Viagra Oral Tablet With Water.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2014

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Planned end date changed from Feb 2011 to Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top